These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 16097370

  • 21. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
    Ueda S, Kato S, Matsuoka H, Kimoto M, Okuda S, Morimatsu M, Imaizumi T.
    Circ Res; 2003 Feb 07; 92(2):226-33. PubMed ID: 12574151
    [Abstract] [Full Text] [Related]

  • 22. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M, Liu L, Guo Z, Xiong Y.
    Eur J Pharmacol; 2008 Apr 14; 584(1):49-56. PubMed ID: 18342305
    [Abstract] [Full Text] [Related]

  • 23. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B, Möller-Ehrlich K, Kress T, Kniepert J, Schwedhelm E, Böger RH, Wanner C, Sauvant C, Schneider R.
    Transl Res; 2013 Aug 14; 162(2):67-76. PubMed ID: 23707198
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. N-acetylcysteine prevents hypertension via regulation of the ADMA-DDAH pathway in young spontaneously hypertensive rats.
    Fan NC, Tsai CM, Hsu CN, Huang LT, Tain YL.
    Biomed Res Int; 2013 Aug 14; 2013():696317. PubMed ID: 24455716
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.
    Palm F, Onozato ML, Luo Z, Wilcox CS.
    Am J Physiol Heart Circ Physiol; 2007 Dec 14; 293(6):H3227-45. PubMed ID: 17933965
    [Abstract] [Full Text] [Related]

  • 30. Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis.
    Segarra G, Cortina B, Mauricio MD, Novella S, Lluch P, Navarrete-Navarro J, Noguera I, Medina P.
    World J Gastroenterol; 2016 Dec 28; 22(48):10545-10556. PubMed ID: 28082806
    [Abstract] [Full Text] [Related]

  • 31. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence.
    Dayoub H, Achan V, Adimoolam S, Jacobi J, Stuehlinger MC, Wang BY, Tsao PS, Kimoto M, Vallance P, Patterson AJ, Cooke JP.
    Circulation; 2003 Dec 16; 108(24):3042-7. PubMed ID: 14638548
    [Abstract] [Full Text] [Related]

  • 32. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.
    Millatt LJ, Whitley GS, Li D, Leiper JM, Siragy HM, Carey RM, Johns RA.
    Circulation; 2003 Sep 23; 108(12):1493-8. PubMed ID: 12952847
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine.
    Yin QF, Fu SH, He P, Xiong Y.
    Atherosclerosis; 2007 Jan 23; 190(1):53-61. PubMed ID: 16533509
    [Abstract] [Full Text] [Related]

  • 35. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
    Yuan Q, Peng J, Liu SY, Wang CJ, Xiang DX, Xiong XM, Hu CP, Li YJ.
    Clin Exp Pharmacol Physiol; 2010 May 23; 37(5-6):630-5. PubMed ID: 20132235
    [Abstract] [Full Text] [Related]

  • 36. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
    Liu LH, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y.
    Cell Physiol Biochem; 2012 May 23; 30(6):1413-22. PubMed ID: 23171931
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Specific Lowering of Asymmetric Dimethylarginine by Pharmacological Dimethylarginine Dimethylaminohydrolase Improves Endothelial Function, Reduces Blood Pressure and Ischemia-Reperfusion Injury.
    Lee Y, Mehrotra P, Basile D, Ullah M, Singh A, Skill N, Younes ST, Sasser J, Shekhar A, Singh J.
    J Pharmacol Exp Ther; 2021 Feb 23; 376(2):181-189. PubMed ID: 33214214
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Regulation of fluid reabsorption in rat or mouse proximal renal tubules by asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase 1.
    Bell T, Araujo M, Luo Z, Tomlinson J, Leiper J, Welch WJ, Wilcox CS.
    Am J Physiol Renal Physiol; 2018 Jul 01; 315(1):F74-F78. PubMed ID: 29513072
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.